Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Clinicians should evaluate for contraindications specific to GLP-1 receptor agonists, including: Personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 History of pancreatitis or gallbladder disease Severe gastroparesis or gastrointestinal disease History of suicidal ideation or behavior Pregnancy or planned pregnancy (pregnancy testing when appropriate) Diabetic retinopathy (requires monitoring in patients with diabetes) Baseline investigations should include TSH, free T4, complete metabolic panel, lipid profile, and hemoglobin A1c (if diabetic or prediabetic)
Long-acting analogs benefit from their extended half-lives in a different way
Indoco Remedies maintains state-of-the-art manufacturing units and follows international quality benchmarks
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications initially designed to treat type 2 diabetes but have since gained recognition for their ability to support significant weight loss
A 5mg vial reconstituted with 2ml bacteriostatic water at a starting dose of 2.5mg weekly provides four weeks of doses, perfectly matching the 28-day optimal stability window
A 4 mL vial at 20mg/mL contains 80mg total, which provides sixteen 5mg doses
US$ 21.16
US$ 21.69
US$ 21.78
US$ 29.24
US$ 21.53
US$ 27.10
US$ 24.58
US$ 22.94
US$ 25.50
US$ 29.40
US$ 20.86
US$ 25.95
